Protalix BioTherapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Protalix BioTherapeutics, Inc.
CIK #0001006281
EDGAR Form CIK 2011 - 2025
10-K [0001006281]
10-Q [0001006281]
3 [0001006281]
4 [0001006281]
8-K [0001006281]
SC 13G [0001006281]
Form 13D/13G Filer Form 13D/13G Subject Filed
Whitebox Advisors LLC Protalix Biotherapeutics Inc [2022-06-09]
Burrage Capital Management LLC Protalix Biotherapeutics Inc [2021-02-12]
Nacht Marius Protalix Biotherapeutics Inc [2020-11-24]
Akirov Alfred Protalix Biotherapeutics Inc [2020-03-30]
Dexcel Pharma Technologies Ltd Protalix Biotherapeutics Inc [2020-03-25]
Highbridge Capital Management LLC Protalix Biotherapeutics Inc [2020-03-23]
Citigroup Inc Protalix Biotherapeutics Inc [2018-02-09]
O'Connor Global Multi-Strategy Alpha Master Ltd Protalix Biotherapeutics Inc [2017-02-15]
UBS OConnor LLC Protalix Biotherapeutics Inc [2017-02-14]
ABIR Therapeutics Ltd Protalix Biotherapeutics Inc [2017-02-01]
View All
Form 3/4/5 Subject 2011 - 2025
Schwartz Aharon
Protalix BioTherapeutics, Inc.
Elze Christian
Naos Yaron
Rubin Eyal
Bashan Dror
Ben Zvi Shmuel
Bar-Shalev Amos
Melincoff Gwen A
Boudes Pol F
Forster Eliot
Hayon Yael
Bronfeld Zeev
Oren Dan
Dexcel Pharma Technologies Ltd.
Almon Einat Brill
Granot David
Shaaltiel Yoseph
Manor Moshe
Maimon Yossi
Camber Capital Management LP
Palash Tzvi
Bio-Cell Ltd
Yanai Shlomo
Akirov Alfred
Aviezer David
Lauterbach Sandra Leigh
Terms | Privacy | Guide
tony@aum13f.com